Skip to main content

ORIGINAL RESEARCH article

Front. Oncol.

Sec. Cancer Immunity and Immunotherapy

Volume 15 - 2025 | doi: 10.3389/fonc.2025.1560625

Single-cell sequencing reveals the role of aggrephagy-related patterns in tumor microenvironment, prognosis and immunotherapy in endometrial cancer

Provisionally accepted
Yuquan Yuan Yuquan Yuan 1Chunyan Ren Chunyan Ren 1Jin Shu Jin Shu 2Keyang Zhu Keyang Zhu 3Ganghui Li Ganghui Li 1Bao Liu Bao Liu 1Jianrong Huang Jianrong Huang 1Yinde Huang Yinde Huang 4Chengzhi Zhao Chengzhi Zhao 1*
  • 1 Chongqing Health Center for Women and Children, Chongqing, China
  • 2 Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Cancer Hospital, Chongqing University, Chongqing, China
  • 3 North Sichuan Medical College, Nanchong, Sichuan Province, China
  • 4 Chongqing General Hospital, Chongqing, Chongqing, China

The final, formatted version of the article will be published soon.

    Background: As a type of autophagy, aggrephagy degrades the aggregation of misfolded protein in cells and plays an important role in key genetic events for various cancers. However, aggrephagy functions within the tumor microenvironment (TME) in endometrial cancer (EC) remain to be elucidated.Methods: A total of 36,227 single cells from single-cell RNA-seq data derived from five EC tumor samples were comprehensively analyzed using a nonnegative matrix factorization (NMF) algorithm for 44 aggrephagy-related genes. Bulk RNA-seq cohorts from public repositories were utilized to assess the prognostic value of aggrephagyrelated TME clusters and predict immune checkpoint blockade immunotherapeutic response in EC.Results: Fibroblasts, macrophages, CD8+T cells, and lymphatic endothelial cells were categorized into two to five aggrephagy-related subclusters, respectively. CellChat analysis showed that the aggrephagy-related subtypes of TME cells exhibited extensive interactions with tumor epithelial cells, particularly for macrophages. Moreover, aggrephagy regulators may be significantly associated with the pseudotime trajectories of major TME cell types as well as the clinical and biological features of EC. Bulk-seq analysis showed that these aggrephagy-related subclusters had significant predictive value for the survival and immune checkpoint blockade response in EC patients.Notably, immunohistochemical staining results manifested that the TUBA1A+ macrophage subtype was linked to less lymph node metastasis and longer survival, which were consistent with the bioinformatics analysis findings.Conclusions: This study provided a novel view of aggrephagy signaling in the EC tumor microenvironment, and intervention of aggrephagy was expected to improve the survival rate of EC patients.

    Keywords: endometrial cancer, Aggrephagy, Tumor Microenvironment, Immunohistochemistry, prognosis

    Received: 15 Jan 2025; Accepted: 04 Mar 2025.

    Copyright: © 2025 Yuan, Ren, Shu, Zhu, Li, Liu, Huang, Huang and Zhao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Chengzhi Zhao, Chongqing Health Center for Women and Children, Chongqing, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    94% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more